Group 1 - The core point of the article is that Fuchuang Precision announced a share reduction by the Taizhou Xiangpu Venture Capital Fund, which decreased its holdings in the company by 9.1863 million shares, representing 3.00% of the total share capital [1] - Following this transaction, the fund's shareholding decreased from 50,039,984 shares to 40,853,661 shares, with the ownership percentage dropping from 16.34% to 13.34% [1] - The equity change has been completed without affecting the company's controlling shareholder or actual controller, and it did not lead to any change in the company's control [1]

Group 1 - The core point of the announcement is the preliminary pricing of the share transfer for Shenyang Fuchuang Precision Equipment Co., Ltd. at 59.88 yuan per share [3][4] - A total of 29 institutional investors participated in the inquiry transfer, including fund management companies, securities firms, qualified foreign institutional investors, private fund managers, and insurance institutions [4] - The total number of shares to be transferred is 9,186,323, which has been fully subscribed by the 29 institutional investors [4] Group 2 - The transfer does not involve any change in the company's control and will not affect its governance structure or ongoing operations [6] - The company assures that the information provided in the announcement is accurate and complete, and it bears legal responsibility for any false or misleading statements [2]

Group 1 - The core point of the article is that 富创精密 (Fuchuang Precision) has disclosed the pricing situation for the transfer of shares through a shareholder inquiry, with the determined transfer price set at 59.88 yuan per share [1] - The inquiry for the share transfer has resulted in full subscription of the proposed shares, with a preliminary determination that 29 institutional investors will be the transferees [1] - The total number of shares to be transferred amounts to 9,186,323 shares [1]

证券代码：688409 证券简称：富创精密 公告编号：2025-088 股东泰州祥浦创业投资基金合伙企业（有限合伙）保证向沈阳富创精密设备 股份有限公司提供的信息内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其真实性、准确性和完整性依法承担法律责任。 本公司及董事会全体成员保证本公告内容与信息披露义务人提供的信息一 致。 重要内容提示： 根据 2025 年 12 月 26 日询价申购情况，初步确定沈阳富创精密设备股份 有限公司（以下简称"公司"）股东本次询价转让（以下简称"本次询价转让"） 的转让价格为 59.88 元/股。 一、本次询价转让初步定价 沈阳富创精密设备股份有限公司 股东询价转让定价情况提示性公告 （二）参与本次询价转让报价的机构投资者家数为 29 家，涵盖了基金管理 公司、证券公司、合格境外机构投资者、私募基金管理人、保险机构等专业机构 投资者。 （三）本次询价转让拟转让股份已获全额认购，初步确定受让方为 29 家机 构投资者，拟受让股份总数为 9,186,323 股。 二、风险提示 （一）本次询价转让受让方及受让股数仅为初步结果，尚存在拟转让股份被 司法冻结、扣划等风险。询价转让的最 ...

人民财讯12月26日电，富创精密(688409)12月26日公告，初步确定公司股东询价转让股份的转让价格为 59.88元/股。此次询价转让拟转让股份已获全额认购，初步确定受让方为29家机构投资者，拟受让股份 总数为918.63万股。 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 股东泰州祥浦创业投资基金合伙企业（有限合伙）保证向沈阳富创精密设备股份有限公司提供的信息内 容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其真实性、准确性和完整性依法承担法律责 任。 重要内容提示： ● 拟参与沈阳富创精密设备股份有限公司（以下简称"富创精密"或"公司"）首发前股东询价转让（以下 简称"本次询价转让"）的股东为泰州祥浦创业投资基金合伙企业（有限合伙）（以下简称"出让方"）； ● 出让方拟转让股份的总数为9,186,323股，占公司总股本的比例为3.00%； ● 本次询价转让不通过集中竞价交易或大宗交易方式进行，不属于通过二级市场减持。受让方通过询价 转让受让的股份，在受让后6个月内不得转让； ● 本次询价转让的受让方为具备相应定价能力和风险承受能力的机构投资者。 一、拟参与转让的股东情况 （一）出让方的名称、持股数量、持股比例 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 出让方委托中信证券股份有限公司（以下简称"中信证券"）组织实施本次询价转让。截至2025年12月25 日，出让方所持首发前股份的数量、占公司总股本比 ...

南方财经12月26日电，富创精密(688409.SH)公告，股东泰州祥浦创业投资基金合伙企业（有限合伙） 拟通过询价方式转让9186323股，占公司总股本3.00%，为其所持股份的18.36%。本次转让价格下限不 低于2025年12月25日前20个交易日均价的70%。受让方限定为具备定价能力和风险承受能力的机构投资 者，受让后6个月内不得转让。 ...

Group 1 - 德方纳米 plans annual equipment maintenance to ensure efficient and stable operation, starting January 1, 2026, for one month, with no significant impact on 2026 performance [1] - 达意隆's subsidiary Tianjin Baolong faces a significant decline in OEM orders due to strategic adjustments from core customers, leading to plans to shut down production lines [2] - 天威视讯's subsidiary plans to transfer project assets for 604.3 million yuan to a related party, constituting a related transaction [3] Group 2 - 金龙羽 intends to sign a strategic cooperation framework agreement with an investment institution to establish an industrial merger fund with a planned scale of 1.5 billion yuan [4] - 紫光国微's subsidiary plans to establish a new company with multiple partners, including a subsidiary of CATL, with a registered capital of 300 million yuan [5] - 信隆健康's major shareholder plans to reduce its stake by up to 1% through trading [6] Group 3 - 龙建股份 wins a 612 million yuan EPC contract for a project, which represents approximately 3.27% of the company's audited revenue for 2024 [7] - 复旦张江 receives acceptance for a clinical trial application for a drug aimed at visualizing malignant lesions in lung cancer patients [9] - 博实股份's major shareholder plans to reduce its stake by up to 2.93% [10] Group 4 - 百纳千成 plans to acquire 100% of Zhonglian Century's shares to expand its marketing business and digital advertising solutions [11] - 天铁科技's major shareholder is under criminal detention, but the investigation is unrelated to the company's operations [12] - 海看股份's shareholder plans to reduce its stake by up to 3.6% [13] Group 5 - 智光电气's subsidiary signs a procurement contract worth 148 million yuan for a high-voltage energy storage system [14] - 西藏矿业's attempt to transfer 100% of a subsidiary's equity has not attracted qualified buyers, leading to automatic withdrawal from the trading platform [15] - 英诺激光's major shareholder plans to reduce its stake by up to 3% [16] Group 6 - 福鞍股份's major shareholder plans to reduce its stake by up to 3% [17] - 白云山 receives a drug registration certificate for a rabies vaccine [18] - 华电科工 signs a contract worth approximately 265 million yuan for a power plant project [19] Group 7 - 康弘药业 receives a drug registration certificate for a medication used to treat schizophrenia [20] - 西菱动力's actual controller plans to reduce their stake by 2% [21] - 海希通讯's actual controller plans to reduce their stake by 0.48% [22] Group 8 - 海南机场 plans to transfer 90% of a subsidiary's equity for approximately 500 million yuan, expecting a profit of about 200 million yuan from the transaction [23] - 森远股份 signs a contract for a computing cluster integration project worth 26.78 million yuan [24] - 丽珠集团's subsidiary receives acceptance for a drug registration application for a new treatment for psoriasis [25] Group 9 - 郑州银行 plans to acquire a village bank and convert it into a branch [26] - 方正证券 announces a cash dividend distribution plan for the third quarter of 2025 [27] - 金陵体育 announces a cash dividend distribution plan for the first three quarters of 2025 [29] Group 10 - 紫金银行 announces a mid-term profit distribution plan for 2025 [30] - *ST建艺's major shareholder waives 1.4 billion yuan in debt and donates 400 million yuan to support the company [31] - 万朗磁塑's major shareholder plans to reduce their stake by up to 3% [32] Group 11 - 艾力斯's core product is included in a list of potential breakthrough therapies for lung cancer [33] - 富创精密's shareholder plans to transfer 918.63 million shares [34] - 东阳光's subsidiary plans to increase capital and introduce investors [35] Group 12 - 侨银股份 plans to acquire a 16.67% partnership in a venture capital fund [36] - 尤夫股份 receives a government subsidy of 4.04 million yuan for a technical improvement project [37] - 倍轻松 and its actual controller are under investigation for information disclosure violations [38] Group 13 - 万润新能 plans to reduce production on some lines for maintenance, expecting a reduction of 5,000 to 20,000 tons in lithium iron phosphate output [39]

格隆汇12月25日丨富创精密(688409.SH)公布，拟参与公司首发前股东询价转让（以下简称"本次询价转 让"）的股东为泰州祥浦创业投资基金合伙企业（有限合伙）（简称"出让方"）；出让方拟转让股份的 总数为9,186,323股，占公司总股本的比例为3.00%。 ...

格隆汇12月25日丨富创精密(688409.SH)公布，拟参与公司首发前股东询价转让（以下简称"本次询价转 让"）的股东为泰州祥浦创业投资基金合伙企业（有限合伙）（简称"出让方"）；出让方拟转让股份的 总数为9,186,323股，占公司总股本的比例为3.00%。 （原标题：富创精密(688409.SH)：本次拟询价转让3.00%股份） ...